ERS Genomics licenses CRISPR gene editing technology to Daiichi Sankyo

Japan |  News | 0 Comment | 14 Jan, 2020

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-...Read more

FDA approves sNDA for Astellas’s antifungal drug

Japan |  News | 0 Comment | 13 Jan, 2020

Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...Read more

Chugai signs licensing deal with Verastem for cancer drug

Japan |  News | 0 Comment | 10 Jan, 2020

Japanses firm Chugai Pharmaceutical Co., Ltd. has announced that the Company entered into a global licensing agreem...Read more

Huya Bioscience ropes in Meiji as distributor for Asian region

Japan |  News | 0 Comment | 10 Jan, 2020

US based HUYA Bioscience International CEO & Executive Chair, Dr. Mireille Gillings announced the appointm...Read more

Alma receives excellence award in Japan

Japan |  News | 0 Comment | 09 Jan, 2020

Alma, a global innovator of Laser, Light-based, Radiofrequency, Plasma and Ultrasound solutions for the aesthetic and su...Read more

Transgene, NEC initiate trials with AI-Powered Cancer Vaccine

Japan |  News | 0 Comment | 07 Jan, 2020

French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of canc...Read more

aTyr Pharma, Kyorin to work on interstitial lung diseases

Japan |  News | 0 Comment | 07 Jan, 2020

US based aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines b...Read more

Urovant inks $300M loan agreement with Sumitomo Pharma

Japan |  News | 0 Comment | 02 Jan, 2020

Urovant Sciences, a subsidiary of Sumitomo Dainippon Pharma has announced that it has entered into a $300 million term l...Read more

Japan develops new tumour-on-a-chip device

Japan |  News | 0 Comment | 01 Jan, 2020

Kyoto University researchers have developed a new 'tumor-on-a-chip' device that can better mimic the environment inside ...Read more

Eisai presented research data on Eribulin (Halaven) at 42nd Annual SABCS2019

Japan |  News | 0 Comment | 16 Dec, 2019

Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halich...Read more

Daiichi Sankyo unveils drug for treating colorectal cancer

Japan |  News | 0 Comment | 31 Dec, 2019

Daiichi Sankyo Company has announced that it has launched the antitumor agent bevacizumab BS for intravenous drip infusi...Read more

Pentax Medical Remains Committed to Endoscopic Ultrasound Business

Japan |  News | 0 Comment | 19 Dec, 2019

PENTAX Medical continues its commitment to Endoscopic Ultrasound (EUS) as an indispensable part of its flexible endoscop...Read more

Astellas strengthens immuno-oncology portfolio by acquiring Xyphos

Japan |  News | 0 Comment | 27 Dec, 2019

Japan based Astellas Pharma Inc. and US headquartered Xyphos Biosciences, Inc. have announced that Astellas has acq...Read more

USFDA approves Daiichi Sankyo and AstraZeneca’s breast cancer drug

Japan |  News | 0 Comment | 26 Dec, 2019

Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU®...Read more

Gilead, Eisai to co-promote drug in Japan for RA treatment

Japan |  News | 0 Comment | 26 Dec, 2019

Gilead Sciences, Inc. and Eisai Co., Ltd. have announced that Gilead Sciences K.K. and Eisai have entered into an agreem...Read more

Eisai gets USFDA nod for insomnia drug

Japan |  News | 0 Comment | 24 Dec, 2019

Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and...Read more

Towa to acquire Esteve’s generic division for 320M euros

Japan |  News | 0 Comment | 24 Dec, 2019

Japan based TOWA PHARMACEUTICAL CO., LTD. and Spain based pharma company ESTEVE have announced that TOWA will acquire 10...Read more

Takeda, Turnstone Biologics to develop novel viral immunotherapies

Japan |  News | 0 Comment | 20 Dec, 2019

US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies,&nb...Read more